(Q54667220)
Statements
Targeting of HER2-expressing tumors using 111In-ABY-025, a second-generation affibody molecule with a fundamentally reengineered scaffold (English)
Sara Ahlgren
Helena Wållberg
Monika Hansson
Mattias Sandström
Richard Lewsley
Anders Wennborg
Lars Abrahmsén
Joachim Feldwisch